Search Result "acquired gefitinib-resistance"

Research Article

An Anti-EGFR/anti- HER2 Bispecific Antibody with Enhanced Antitumor Activity Against Acquired Gefitinib-Resistant NSCLC Cells

Journal: Protein & Peptide Letters
Volume: 28 Issue: 11 Year: 2021 Page: 1290-1297
Author(s): Yan Si,Xinxin Pei,Xiangfang Wang,Qianqian Han,Changzhi Xu,Buchang Zhang

Research Article

Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway

Journal: Current Cancer Drug Targets
Volume: 17 Issue: 4 Year: 2017 Page: 376-385
Author(s): Ruzhen Zheng,Hao Jiang,Jinhui Li,Xinge Liu,Hongwei Xu

Case Report

Pulmonary Adenocarcinoma Patient with Complex Mutations on EGFRBenefits from Furmonertinib after Acquiring Gefitinib Resistance: A CaseReport

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 2 Year: 2024 Page: 247-252
Author(s):

Research Article

Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 22 Issue: 3 Year: 2021 Page: 389-399
Author(s): Xiaoming Huang,Jingchun Sun,Jianli Sun

An Integrative Analysis of the Putative Gefitinib-resistance Related Genes in a Lung Cancer Cell Line Model System

Journal: Current Cancer Drug Targets
Volume: 15 Issue: 5 Year: 2015 Page: 423-434
Author(s): Xiaohong Han,Manjiao Liu,Shuai Wang,Guanting Lv,Li Ma,Changqing Zeng,Yuankai Shi

Combined Cancer Therapy: Strategies to Overcome Acquired Aromatase Inhibitor Resistance

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 42 Year: 2014 Page: 6575-6583
Author(s): Susan B. Kesmodel,Gauri J. Sabnis,Saranya Chumsri,Angela M.H. Brodie

Research Article

Structural Basis for Drug Resistance Mechanisms Against EGFR

Journal: Current Topics in Medicinal Chemistry
Volume: 17 Issue: 22 Year: 2017 Page: 2509-2521
Author(s): Sukriti Goyal,Salma Jamal,Asheesh Shanker,Abhinav Grover

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 818-832
Author(s): Elena Galvani,Roberta Alfieri,Elisa Giovannetti,Andrea Cavazzoni,Silvia La Monica,Maricla Galetti,Claudia Fumarola,Mara Bonelli,Marco Mor,Marcello Tiseo,Godefridus J. Peters,Pier Giorgio Petronini,Andrea Ardizzoni

Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3894-3900
Author(s): Paolo Maione,Antonio Rossi,Marianna Bareschino,Paola Claudia Sacco,Clorinda Schettino,Francesca Casaluce,Assunta Sgambato,Cesare Gridelli

Review Article

Pharmacokinetics of Gefitinib: Roles of Drug Metabolizing Enzymes and Transporters

Journal: Current Drug Delivery
Volume: 14 Issue: 2 Year: 2017 Page: 282-288
Author(s): Can Zhao,Shu-Yan Han,Ping-Ping Li

Previous   Next

Go To   Results 1 - 1 of 582

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2025 Bentham Science Publishers | Privacy Policy